[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599642":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":29,"centralContacts":33,"locations":39,"responsibleParty":60,"collaborators":62,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":10,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":10,"enrollmentInfo":75,"targetDuration":10,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Samples from Persons Living With HIV (PLWH)",null,"Participants will complete an online survey and receive a sample collection kit in the United States (US) mail. Two saliva samples will be obtained at home (one sample collected with two foam swabs and applied to a single FTA indicating card) and one oral rinse and gargle sample. Participants will complete a follow-up survey, and 7-10 days after the date of home sample collection, participants will visit the UCSF Anal Neoplasia Clinic, Research and Education (ANCRE) Clinic at Mt. Zion for a 15-minute clinic visit. During this clinic visit, participants will additionally complete one oral rinse and gargle sample.",[13,14],"Diagnostic Test: Mail-based Saliva Sample Kit","Other: Study-related Surveys",[16,23],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"DIAGNOSTIC_TEST","Mail-based Saliva Sample Kit","Sent via United States Postal Service and returned via FedEx",[9],[22],"Mail-based Specimen Sample Kit",{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"Study-related Surveys","Online surveys will be administered",[9],[28],"Web-based Surveys",[30],{"name":31,"affiliation":5,"role":32},"Alexandra Hernandez Levenston, MD, MPH","PRINCIPAL_INVESTIGATOR",[34],{"name":35,"role":36,"phone":37,"phoneExt":10,"email":38},"William Juarez","CONTACT","415-949-8336","William.Juarez@ucsf.edu",[40],{"facility":5,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","San Francisco","California","94143","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-122.41942,37.77493,{"lat":51,"lon":50},[54,56,59],{"name":35,"role":36,"phone":37,"phoneExt":10,"email":55},"william.Juarez@ucsf.edu",{"name":10,"role":36,"phone":57,"phoneExt":10,"email":58},"877-827-3222","cancertrials@ucsf.edu",{"name":31,"role":32,"phone":10,"phoneExt":10,"email":10},{"type":61,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[63],{"name":64,"class":65},"National Institute of Dental and Craniofacial Research (NIDCR)","NIH","100599642","feasibility-of-hpv-testing-with-mail-delivered-sample-collection-kits-100599642",false,"NCT07087145","Feasibility of HPV Testing With Mail-delivered Sample Collection Kits","Persistent Oral HPV Among Diverse PLWH: A Pilot Study to Evaluate the Feasibility and Acceptability of Testing for Oral HPV DNA Infection With Mail-delivered Sample Collection Kits","Inclusion Criteria:\n\n1. Over 35 years of age\n2. Member of a sexual or gender group considered sexual minority men (men who have sex with men, trans-women)\n3. Person living with HIV\n4. Willing and able to receive a package through United States (US) postal service\n5. Willing and able to return a package through FedEx\n6. Able to attend a clinic visit at University of California, San Francisco (UCSF) Mt. Zion campus\n\nExclusion Criteria:\n\n* Does not meet the above criteria","ALL","35 Years",{"count":76,"type":77},135,"ESTIMATED","OBSERVATIONAL","People living with human immunodeficiency virus (PLWH) have an estimated 1.6-6.0 times increased risk of developing oropharyngeal cancer (OPC) compared with individuals in the general population. 70% of OPCs are caused by human papillomavirus (HPV), and PLWH also have an increased prevalence of oral HPV infection. Disparities by race\u002Fethnicity also include a later stage of diagnosis and less frequent cancer-directed treatment for members of ethnic minority groups. There is little known regarding the racial\u002Fethnic differences in oral HPV infection, persistence of oral HPV infection, or progression of oral HPV infection to OPC among PLWH. This is an observational, prospective cohort study to investigate the feasibility of alternative sample collection methods for HPV testing among PLWH.",[81,82,83],"HPV Infection","HIV Infections","HPV-Related Malignancy",[85],"HPV Testing","2025-07-29",{"date":88,"type":89},"2025-08-01","ACTUAL",{"date":91,"type":89},"2024-11-17",{"date":93,"type":77},"2026-12-31",{"name":5,"class":6},1]